Prelude has shown strategic foresight by initiating collaborations with established pharmaceutical companies. Notably, the company plans to begin a combination trial of PRT3789 with Merck's ...

Lawson covers the Healthcare sector, focusing on stocks such as Relay Therapeutics, Arcus Biosciences, and Syndax Pharmaceuticals. In addition to Barclays, Prelude Therapeutics also received a Sell ...

UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday Avi Kapoor Best Buy To Rally More Than 21%? Here Are 10 Top ...